# Standard-of-care Systemic Therapy With or Without Local Therapy in Patients With Oligoprogressive Non-Small Cell Lung Cancer(NSCLC）

> **NCT07076693** · PHASE2,PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Shanghai Chest Hospital** · enrollment: 97 (estimated)

## Conditions studied

- OligoProgressive Metastatic Disease
- Non-Small Cell Lung Cancer

## Interventions

- **PROCEDURE:** Radiotherapy or Surgery
- **DRUG:** Standard Medical Therapy

## Key facts

- **NCT ID:** NCT07076693
- **Lead sponsor:** Shanghai Chest Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-06-03
- **Primary completion:** 2028-05-31
- **Final completion:** 2028-05-31
- **Target enrollment:** 97 (ESTIMATED)
- **Last updated:** 2025-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07076693

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07076693, "Standard-of-care Systemic Therapy With or Without Local Therapy in Patients With Oligoprogressive Non-Small Cell Lung Cancer(NSCLC）". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT07076693. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*